215 related articles for article (PubMed ID: 35027829)
21. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
22. ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy.
Wang J; Chen W; Du W; Zhang H; Ilmer M; Song L; Hu Y; Ma X
Int J Nanomedicine; 2023; 18():2389-2409. PubMed ID: 37192893
[TBL] [Abstract][Full Text] [Related]
23. Sinoporphyrin sodium based sonodynamic therapy induces anti-tumor effects in hepatocellular carcinoma and activates p53/caspase 3 axis.
Li E; Sun Y; Lv G; Li Y; Zhang Z; Hu Z; Cao W
Int J Biochem Cell Biol; 2019 Aug; 113():104-114. PubMed ID: 30660690
[TBL] [Abstract][Full Text] [Related]
24. High expression of TBRG4 in relation to unfavorable outcome and cell ferroptosis in hepatocellular carcinoma.
Tao S; Cui D; Cheng H; Liu X; Jiang Z; Chen H; Gao Y
BMC Cancer; 2024 Feb; 24(1):194. PubMed ID: 38347489
[TBL] [Abstract][Full Text] [Related]
25. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
26. 'Mito-Bomb': a novel mitochondria-targeting nanosystem for ferroptosis-boosted sonodynamic antitumor therapy.
Wang J; Zhao Z; Liu Y; Cao X; Li F; Ran H; Cao Y; Wu C
Drug Deliv; 2022 Dec; 29(1):3111-3122. PubMed ID: 36131565
[TBL] [Abstract][Full Text] [Related]
27. Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy.
Dong L; Zhou S; Bai X; He X
Front Pharmacol; 2023; 14():1090895. PubMed ID: 36992841
[No Abstract] [Full Text] [Related]
28. Nanodroplet-enhanced sonodynamic therapy potentiates immune checkpoint blockade for systemic suppression of triple-negative breast cancer.
Wu W; Xu M; Qiao B; Huang T; Guo H; Zhang N; Zhou L; Li M; Tan Y; Zhang M; Xie X; Shuai X; Zhang C
Acta Biomater; 2023 Mar; 158():547-559. PubMed ID: 36539109
[TBL] [Abstract][Full Text] [Related]
29. CRISPR screens uncover protective effect of PSTK as a regulator of chemotherapy-induced ferroptosis in hepatocellular carcinoma.
Chen Y; Li L; Lan J; Cui Y; Rao X; Zhao J; Xing T; Ju G; Song G; Lou J; Liang J
Mol Cancer; 2022 Jan; 21(1):11. PubMed ID: 34983546
[TBL] [Abstract][Full Text] [Related]
30. Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma.
Xu L; Zheng Q; Liu W
BMC Cancer; 2022 Mar; 22(1):229. PubMed ID: 35236323
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
Yang X; Mei M; Yang J; Guo J; Du F; Liu S
Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
[TBL] [Abstract][Full Text] [Related]
32. Indocyanine Green-Loaded Nanobubbles Targeting Carbonic Anhydrase IX for Multimodal Imaging of Renal Cell Carcinoma.
Zhong C; Chen J; Ling Y; Liu D; Xu J; Wang L; Ge C; Jiang Q
Int J Nanomedicine; 2023; 18():2757-2776. PubMed ID: 37250472
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.
Zhao RR; Wu JH; Tong LW; Li JY; Lu YS; Shao JW
J Colloid Interface Sci; 2024 Apr; 660():257-276. PubMed ID: 38244494
[TBL] [Abstract][Full Text] [Related]
34. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
Wan S; Lei Y; Li M; Wu B
Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
[TBL] [Abstract][Full Text] [Related]
35. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional nanobubbles carrying indocyanine green and paclitaxel for molecular imaging and the treatment of prostate cancer.
Lan M; Zhu L; Wang Y; Shen D; Fang K; Liu Y; Peng Y; Qiao B; Guo Y
J Nanobiotechnology; 2020 Sep; 18(1):121. PubMed ID: 32883330
[TBL] [Abstract][Full Text] [Related]
37. Anti-tumor immunity and ferroptosis of hepatocellular carcinoma are enhanced by combined therapy of sorafenib and delivering modified GO-based PD-L1 siRNAs.
Li Z; Bu J; Zhu X; Zhou H; Ren K; Chu PK; Li L; Hu X; Ding X
Biomater Adv; 2022 May; 136():212761. PubMed ID: 35929305
[TBL] [Abstract][Full Text] [Related]
38. Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis.
Zhang X; Chen Y; Li X; Xu H; Yang J; Wang C; Zhang C; Deng Y; Lu A; Zheng C; Lu J
Eur J Med Chem; 2024 Mar; 267():116183. PubMed ID: 38354520
[TBL] [Abstract][Full Text] [Related]
39. A prognostic signature based on the expression profile of the ferroptosis-related long non-coding RNAs in hepatocellular carcinoma.
Lin X; Yang S
Adv Clin Exp Med; 2022 Oct; 31(10):1099-1109. PubMed ID: 35581934
[TBL] [Abstract][Full Text] [Related]
40. A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma.
Ji L; Zhang Q; Cao Y; Liu L
Hum Cell; 2023 May; 36(3):1173-1189. PubMed ID: 36892792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
